Vitamin e antioxydants  

     

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultAll cause deathstroke (fatal and non fatal)

cardiovascular prevention  

GISSI, 1999     vitamin EcontrolRisk of bias negative-8%-13%
PPP, 2001     vitamin EcontrolRisk of bias negative7%24%
ATBC vitamin E, 1994     vitamin EplaceboLow risk of bias suggesting-7%
CHAOS, 1996   vitamin EplaceboLow risk of bias suggesting29%
HOPE, 2000     vitamin EplaceboLow risk of bias negative17%
AREDS, 2001     vitamin EplaceboLow risk of bias negative5%
SPACE, 2000     vitamin EplaceboLow risk of bias suggesting9%-15%
Linxian, 1993     vitamin Eplacebonegative
WACS vitamin E, 2007        NCTvitamin EplaceboLow risk of bias negative2%-15%
PHS II vitamin E, 2008    NCTvitamin EplaceboLow risk of bias negative 3%5%
WHS vitamin E, 2005      NCTvitamin EplaceboLow risk of bias negative-2%
HOPE renal insufficiency subgroup, 2004     vitamin EplaceboLow risk of bias negative-10%3%
ASAP, 2000         vitamin EplaceboLow risk of bias negative100%
ATBC 2nd prev subgroup (vitamin E), 1998       vitamin EplaceboLow risk of bias negative

peripheral vascular diseases  

Livingstone, 1958   placebo -
Hamilton, 1953   placebo -